Consent to the Distribution of New Medicines

Notice Type: Departmental
Notice Title: Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines, which were referred to the Minister of Health under the provisions of section 24(5) of the Act, and are set out in the Schedule hereto:

Schedule

Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Apo-Bromocriptine Bromocriptine mesilate 2.9mg equivalent to bromocriptine 2.5mg Tablet Apotex NZ Limited Apotex Inc, Weston, Canada
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Colofac Mebeverine hydrochloride 135mg Tablet BGP Products Mylan Laboratories SAS, Chatillon sur Charlaronne, France
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Keytruda Pembrolizumab 50mg Powder for infusion Merck Sharp & Dohme (New Zealand) Limited MSD International GmbH, Innishannon, Ireland

Dated this 3rd day of July 2017.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Publication Date: 6 Jul 2017

Tags: Medicines Act Consent to the distribution of new medicines Health

Notice Number: 2017-go3433
Issue Number: 71

Title: View PDF
Description: Principal Edition, 6 July 2017
File Type and Size: PDF (21 KB)
Page Number 0

Tags

Notice Number

Issue Number